$MDLZ
Mondelez International, Inc.

2024 Q3 Form 10-Q Financial Statement

#000110398224000092 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $9.204B $8.343B $9.314B
YoY Change 1.94% -1.93% 7.12%
Cost Of Revenue $6.205B $5.546B $5.844B
YoY Change 12.1% 7.63% 3.99%
Gross Profit $2.999B $2.797B $3.470B
YoY Change -14.17% -16.61% 12.85%
Gross Profit Margin 32.58% 33.53% 37.26%
Selling, General & Admin $1.630B $1.891B $2.221B
YoY Change -19.27% 2.6% 4.81%
% of Gross Profit 54.35% 67.61% 64.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $335.0M $317.0M $313.0M
YoY Change 8.41% 9.31% 8.68%
% of Gross Profit 11.17% 11.33% 9.02%
Operating Expenses $1.630B $1.891B $2.258B
YoY Change -19.27% 0.59% 4.78%
Operating Profit $1.153B $854.0M $1.212B
YoY Change -16.39% -42.06% 31.74%
Interest Expense -$129.0M -$130.0M -$118.0M
YoY Change -4.44% -61.08% 37.21%
% of Operating Profit -11.19% -15.22% -9.74%
Other Income/Expense, Net -$46.00M -$32.00M $88.00M
YoY Change -30.3% -145.07% 266.67%
Pretax Income $1.132B $850.0M $1.163B
YoY Change -14.95% -26.79% 50.65%
Income Tax $326.0M $295.0M $257.0M
% Of Pretax Income 28.8% 34.71% 22.1%
Net Earnings $853.0M $601.0M $950.0M
YoY Change -13.31% -36.33% 62.95%
Net Earnings / Revenue 9.27% 7.2% 10.2%
Basic Earnings Per Share $0.64 $0.45
Diluted Earnings Per Share $0.63 $0.45 $0.70
COMMON SHARES
Basic Shares Outstanding 1.336B shares 1.341B shares 1.361B shares
Diluted Shares Outstanding 1.344B shares 1.348B shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.517B $1.471B $1.810B
YoY Change -5.78% -0.74% -5.88%
Cash & Equivalents $1.573B $1.471B $1.884B
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $2.723B $5.751B $1.766B
YoY Change 50.78% 127.31% 100.68%
Inventory $4.270B $4.009B $3.615B
Prepaid Expenses
Receivables $3.800B $3.165B $3.634B
Other Receivables $891.0M $846.0M $878.0M
Total Short-Term Assets $13.20B $15.17B $11.70B
YoY Change 14.64% 30.53% 15.97%
LONG-TERM ASSETS
Property, Plant & Equipment $10.47B $10.12B $10.38B
YoY Change 7.38% 1.72% 7.2%
Goodwill $23.77B $23.39B $23.90B
YoY Change 2.0% -1.2% 1.9%
Intangibles $19.46B $19.40B $19.84B
YoY Change -0.08% -2.23% 0.64%
Long-Term Investments $2.600B $2.500B $3.242B
YoY Change -16.13% -22.96% -33.55%
Other Assets $1.194B $1.238B $886.0M
YoY Change -45.05% -66.59% -52.42%
Total Long-Term Assets $58.99B $57.93B $59.69B
YoY Change -0.6% -4.1% -2.26%
TOTAL ASSETS
Total Short-Term Assets $13.20B $15.17B $11.70B
Total Long-Term Assets $58.99B $57.93B $59.69B
Total Assets $72.19B $73.10B $71.39B
YoY Change 1.88% 1.49% 0.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.110B $8.370B $8.321B
YoY Change 18.96% 8.14% 10.04%
Accrued Expenses $3.626B $3.301B $3.841B
YoY Change -3.23% -1.08% 15.73%
Deferred Revenue
YoY Change
Short-Term Debt $1.484B $838.0M $420.0M
YoY Change 21.54% -61.52% -81.73%
Long-Term Debt Due $1.821B $2.774B $2.101B
YoY Change -22.64% 207.88% 448.56%
Total Short-Term Liabilities $21.07B $22.43B $19.01B
YoY Change 11.29% 24.6% 13.64%
LONG-TERM LIABILITIES
Long-Term Debt $16.50B $16.14B $16.89B
YoY Change 0.54% -11.05% -16.61%
Other Long-Term Liabilities $2.191B $2.471B $2.735B
YoY Change -11.62% -32.71% 1.75%
Total Long-Term Liabilities $2.191B $2.471B $2.735B
YoY Change -11.62% -88.68% 1.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.07B $22.43B $19.01B
Total Long-Term Liabilities $2.191B $2.471B $2.735B
Total Liabilities $44.30B $45.38B $43.03B
YoY Change 4.73% 4.61% -2.75%
SHAREHOLDERS EQUITY
Retained Earnings $35.33B $35.11B $34.24B
YoY Change 4.33% 4.93% 8.75%
Common Stock $32.24B $32.20B $32.22B
YoY Change 0.2% 0.16% 0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.85B $27.69B $28.33B
YoY Change
Total Liabilities & Shareholders Equity $72.19B $73.10B $71.39B
YoY Change 1.88% 1.49% 0.32%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income $853.0M $601.0M $950.0M
YoY Change -13.31% -36.33% 62.95%
Depreciation, Depletion And Amortization $335.0M $317.0M $313.0M
YoY Change 8.41% 9.31% 8.68%
Cash From Operating Activities $1.305B $822.0M $1.564B
YoY Change 10.88% -3.29% 12.36%
INVESTING ACTIVITIES
Capital Expenditures $316.0M $367.0M $332.0M
YoY Change 10.88% 34.93% -216.49%
Acquisitions
YoY Change
Other Investing Activities -$7.000M -$34.00M $1.358B
YoY Change -100.85% -103.84% -213.83%
Cash From Investing Activities -$323.0M -$401.0M $1.026B
YoY Change -160.26% -165.31% -169.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -954.0M -381.0M -2.484B
YoY Change -37.85% -78.62% 1462.26%
NET CHANGE
Cash From Operating Activities 1.305B 822.0M 1.564B
Cash From Investing Activities -323.0M -401.0M 1.026B
Cash From Financing Activities -954.0M -381.0M -2.484B
Net Change In Cash 28.00M 40.00M 106.0M
YoY Change -84.27% -112.58% -143.27%
FREE CASH FLOW
Cash From Operating Activities $1.305B $822.0M $1.564B
Capital Expenditures $316.0M $367.0M $332.0M
Free Cash Flow $989.0M $455.0M $1.232B
YoY Change 10.87% -21.28% -26.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1884000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1948000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
702000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1074000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1151000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
74000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1604000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-108000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-413000000 usd
CY2024Q2 us-gaap Dividends Cash
DividendsCash
569000000 usd
us-gaap Dividends Cash
DividendsCash
1144000000 usd
CY2023Q2 us-gaap Dividends Cash
DividendsCash
525000000 usd
us-gaap Dividends Cash
DividendsCash
1053000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
-665000000 usd
mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
464000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
79000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
106000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
82000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
102000000 usd
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
605000000 usd
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
229000000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
593000000 usd
mdlz Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
414000000 usd
mdlz Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-186000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
189000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
569000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2056000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
596000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1055000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
98000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3539000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-79000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-395000000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
72000000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
74000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1471000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1884000000 usd
CY2024Q2 mdlz Accounts Receivable Sold Under Factoring Program Principal Amount Outstanding
AccountsReceivableSoldUnderFactoringProgramPrincipalAmountOutstanding
739000000 usd
CY2023Q4 mdlz Accounts Receivable Sold Under Factoring Program Principal Amount Outstanding
AccountsReceivableSoldUnderFactoringProgramPrincipalAmountOutstanding
262000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
53000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
68000000 usd
CY2024Q2 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2700000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2400000000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1157000000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
973000000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3010000000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2790000000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
4167000000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
3763000000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
158000000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
148000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4009000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3615000000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
17563000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
17690000000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
8075000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7996000000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9488000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9694000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
666000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
364000000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
471000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
23450000000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
473000000 usd
CY2023 mdlz Goodwill Acquired During Period Net Of Adjustment
GoodwillAcquiredDuringPeriodNetOfAdjustment
-27000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
23896000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-510000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
23386000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3267000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2197000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1070000000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18327000000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18327000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18669000000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21594000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2197000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19397000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
75000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
76000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
125000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
125000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
125000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
90000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
90000000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
705000000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
2500000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3200000000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
48000000 usd
CY2024Q2 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
2000000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
71000000 usd
CY2023Q2 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
79000000 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
82000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
106000000 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
102000000 usd
CY2024Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-612000000 eur
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-665000000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
838000000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
420000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
0 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
130000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
145000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
252000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
298000000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
98000000 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
49000000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
152000000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
107000000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-97000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-192000000 usd
CY2024Q2 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
5500000000 usd
CY2024Q2 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
4493000000 usd
CY2023Q4 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
1597000000 usd
CY2023Q4 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1559000000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
1007000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
38000000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
661000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
680000000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
50700000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
50700000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18678120 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.96
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
420000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2267960 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
73.12
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2213764 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
43.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
67000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
239408 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
59.98
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18492908 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.50
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
238000000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
96000000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
1000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
11000000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4553166 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
62.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2351551 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
69.58
mdlz Weighted Average Grant Date Fair Value Stock Granted
WeightedAverageGrantDateFairValueStockGranted
164000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1972046 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
58.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
116000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
214676 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
65.45
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4717995 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
67.54
CY2024Q2 mdlz Share Based Compensation Tax Benefit Realized From Stock Awards Vesting
ShareBasedCompensationTaxBenefitRealizedFromStockAwardsVesting
0 usd
mdlz Share Based Compensation Tax Benefit Realized From Stock Awards Vesting
ShareBasedCompensationTaxBenefitRealizedFromStockAwardsVesting
7000000 usd
CY2024Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2000000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
21000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
41000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-385000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
96000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-577000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
231000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-2000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-8000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-8000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-6000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-383000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
104000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-569000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
237000000 usd
CY2024Q2 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.278
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.347
CY2024Q2 mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.285
CY2024Q2 mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.285
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.262
mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.272
mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.272
CY2023Q2 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.246
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.273
mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.236
mdlz Effective Income Tax Rate Reconciliation Excluding Tax Impacts Percent
EffectiveIncomeTaxRateReconciliationExcludingTaxImpactsPercent
0.236
CY2024Q2 us-gaap Profit Loss
ProfitLoss
603000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
941000000 usd
us-gaap Profit Loss
ProfitLoss
2019000000 usd
us-gaap Profit Loss
ProfitLoss
3030000000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
944000000 usd
us-gaap Net Income Loss
NetIncomeLoss
2013000000 usd
us-gaap Net Income Loss
NetIncomeLoss
3025000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1343000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1364000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1346000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1365000000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1348000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1372000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1352000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1372000000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.22
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.20
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2024Q2 us-gaap Revenues
Revenues
8343000000 usd
CY2023Q2 us-gaap Revenues
Revenues
8507000000 usd
us-gaap Revenues
Revenues
17633000000 usd
us-gaap Revenues
Revenues
17673000000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-571000000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
171000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
553000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
220000000 usd
CY2024Q2 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
67000000 usd
CY2023Q2 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
79000000 usd
mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
134000000 usd
mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
156000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
75000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
76000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
854000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1425000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3581000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2930000000 usd
CY2024Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-28000000 usd
CY2023Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-22000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-51000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-41000000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-97000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-192000000 usd
CY2024Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-189000000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
607000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
850000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1161000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3532000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3386000000 usd
CY2024Q2 us-gaap Revenues
Revenues
8343000000 usd
CY2023Q2 us-gaap Revenues
Revenues
8507000000 usd
us-gaap Revenues
Revenues
17633000000 usd
us-gaap Revenues
Revenues
17673000000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001103982-24-000092-index-headers.html Edgar Link pending
0001103982-24-000092-index.html Edgar Link pending
0001103982-24-000092.txt Edgar Link pending
0001103982-24-000092-xbrl.zip Edgar Link pending
ex101_63024.htm Edgar Link pending
ex102_63024.htm Edgar Link pending
ex103_63024.htm Edgar Link pending
ex104_63024.htm Edgar Link pending
ex105_63024.htm Edgar Link pending
ex106_63024.htm Edgar Link pending
ex107_63024.htm Edgar Link pending
ex108_63024.htm Edgar Link pending
ex109_63024.htm Edgar Link pending
ex311_63024.htm Edgar Link pending
ex312_63024.htm Edgar Link pending
ex321_63024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdlz-20240630.htm Edgar Link pending
mdlz-20240630.xsd Edgar Link pending
mdlz-20240630_g1.jpg Edgar Link pending
mdlz-20240630_g2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mdlz-20240630_cal.xml Edgar Link unprocessable
mdlz-20240630_def.xml Edgar Link unprocessable
mdlz-20240630_lab.xml Edgar Link unprocessable
mdlz-20240630_pre.xml Edgar Link unprocessable
mdlz-20240630_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending